Pollen-induced asthma: diagnostic and therapeutic implications

Evidence supports the hypothesis of pollen-induced asthma as a specific asthma phenotype, with defined clinical features and tailored pathways for its clinical management. The probability of diagnosis varies significantly in the pollen season, in which allergic patients are symptomatic, as compared to asymptomatic periods outside the pollen season. In this context, a novel diagnostic scheme for pollen-induced asthma has been developed. Pollen exposure is the key risk factor for symptoms and exacerbations. Therefore, we proposed a therapeutic algorithm for pollen-induced asthma based on a risk stratification model that considers the medical history of the patients and the measurement of objective markers, allowing a tailored therapeutic approach.